SUSQUEHANNA INTERNATIONAL GROUP, LLP
Position in DNTH — Dianthus Therapeutics, Inc. /DE/
CIK 1446194
BALA CYNWYD, PA
Position in DNTH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,947,502
-$3,766,181 QoQ
Shares Held
30,237
-62.2% QoQ
Ownership
0.054%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#123
of 269 holders
Holding Since
Jun 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNTH Over Time
Shares Held
Position Value (USD)
Derivatives in DNTH
reported options exposure · as of Jun 30, 2026CallValue
$9,133,876
CallShares
93,700
PutValue
$7,116,040
PutShares
73,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,649,997,309 across 349 Biotechnology names. DNTH ranks #68 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
1,053,896 | $140,442,180 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,549,458 | $131,998,327 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
180,219 | $112,373,755 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
294,460 | $88,641,293 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
148,610 | $79,796,139 | |
| 6 | INSM |
INSMED Inc
|
729,354 | $77,763,723 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
144,174 | $71,615,550 | |
| 8 | AGIO |
Agios Pharmaceuticals, Inc.
|
1,375,558 | $51,046,957 |
All Filings in DNTH
Export CSV
33 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,116,040 | 73,000 | Put | Other | 2026-08-14 | |
| 2026-06-30 | $2,947,502 | 30,237 | Shares | Other | 2026-08-14 | |
| 2026-06-30 | $9,133,876 | 93,700 | Call | Other | 2026-08-14 | |
| 2026-03-31 | $6,713,683 | 80,001 | Shares | Other | 2026-05-15 | |
| 2026-03-31 | $5,496,760 | 65,500 | Call | Other | 2026-05-15 | |
| 2026-03-31 | $11,891,464 | 141,700 | Put | Other | 2026-05-15 | |
| 2025-12-31 | $2,120,913 | 51,466 | Shares | Other | 2026-02-17 | |
| 2025-12-31 | $799,474 | 19,400 | Call | Other | 2026-02-17 | |
| 2025-12-31 | $894,257 | 21,700 | Put | Other | 2026-02-17 | |
| 2025-09-30 | $474,600 | 12,061 | Shares | Other | 2025-11-14 | |
| 2025-09-30 | $6,815,420 | 173,200 | Put | Other | 2025-11-14 | |
| 2025-09-30 | $5,595,570 | 142,200 | Call | Other | 2025-11-14 | |
| 2025-06-30 | $560,148 | 30,067 | Shares | Other | 2025-08-14 | |
| 2025-06-30 | $581,256 | 31,200 | Call | Other | 2025-08-14 | |
| 2025-06-30 | $478,791 | 25,700 | Put | Other | 2025-08-14 | |
| 2025-03-31 | $1,480,224 | 81,600 | Put | Other | 2025-05-14 | |
| 2025-03-31 | $859,436 | 47,378 | Shares | Other | 2025-05-14 | |
| 2024-12-31 | $360,179 | 16,522 | Shares | Other | 2025-02-14 | |
| 2024-03-31 | $6,164,610 | 205,487 | Shares | Defined | 2024-05-07 | |
| 2023-12-31 | $298,261 | 28,679 | Shares | Defined | 2024-02-14 | |
| 2023-06-30 MGTA | — | 103,302 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 MGTA | — | 181,503 | Shares | Defined | 2023-05-16 | |
| 2022-06-30 MGTA | — | 45,968 | Shares | Defined | 2022-08-15 | |
| 2021-12-31 MGTA | — | 10,435 | Shares | Defined | 2022-04-05 | |
| 2021-06-30 MGTA | — | 20,600 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 MGTA | — | 27,200 | Call | Defined | 2021-05-17 | |
| 2021-03-31 MGTA | — | 15,400 | Put | Defined | 2021-05-17 | |
| 2021-03-31 MGTA | — | 26,963 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 MGTA | — | 14,554 | Shares | Defined | 2021-02-16 | |
| 2020-12-31 MGTA | — | 20,700 | Put | Defined | 2021-02-16 | |
| 2020-09-30 MGTA | — | 19,180 | Shares | Defined | 2020-11-16 | |
| 2020-09-30 MGTA | — | 12,700 | Put | Defined | 2020-11-16 | |
| 2020-06-30 MGTA | — | 15,100 | Put | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||